Karyopharm Therapeutics Inc Financial Flexibility Index
Karyopharm Therapeutics Inc financial flexibility index. Karyopharm Therapeutics Inc (KPTI) has a Financial Flexibility Index of -0.06x as of June 2026. Free cash flow of $-24.93 Million (operating CF $-24.93 Million minus capex $0.00) represents 0% of total liabilities ($441.49 Million). See KPTI free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Karyopharm Therapeutics Inc (2011–2025)
Financial flexibility index of Karyopharm Therapeutics Inc from 2011 to 2025. Historical Financial Flexibility Index trend for Karyopharm Therapeutics Inc across 15 annual periods. Check KPTI cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Karyopharm Therapeutics Inc Financial Flexibility Index by Year (2011–2025)
Karyopharm Therapeutics Inc financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Karyopharm Therapeutics Inc. For the full cash flow conversion analysis, see Karyopharm Therapeutics Inc (KPTI) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.19x | $-75.37 Million | $-75.37 Million | $401.34 Million | ▲ +48.3% |
| 2024 | -0.36x | $-127.34 Million | $-127.49 Million | $350.44 Million | ▼ -47.6% |
| 2023 | -0.25x | $-92.72 Million | $-92.72 Million | $376.64 Million | ▲ +38.3% |
| 2022 | -0.40x | $-149.44 Million | $-149.55 Million | $374.83 Million | ▼ -51.4% |
| 2021 | -0.26x | $-101.40 Million | $-107.12 Million | $384.98 Million | ▲ +56.8% |
| 2020 | -0.61x | $-160.09 Million | $-160.23 Million | $262.50 Million | ▲ +21.6% |
| 2019 | -0.78x | $-190.62 Million | $-190.82 Million | $245.19 Million | ▲ +21.6% |
| 2018 | -0.99x | $-156.75 Million | $-159.12 Million | $158.02 Million | ▲ +31.5% |
| 2017 | -1.45x | $-73.66 Million | $-73.72 Million | $50.83 Million | ▲ +68.8% |
| 2016 | -4.65x | $-84.32 Million | $-84.39 Million | $18.14 Million | ▲ +14.3% |
| 2015 | -5.42x | $-92.61 Million | $-94.03 Million | $17.08 Million | ▼ -51.1% |
| 2014 | -3.59x | $-48.61 Million | $-51.45 Million | $13.54 Million | ▲ +60.9% |
| 2013 | -9.18x | $-30.23 Million | $-30.29 Million | $3.29 Million | ▼ -1642.0% |
| 2012 | -0.53x | $-15.39 Million | $-15.51 Million | $29.19 Million | ▼ -28.2% |
| 2011 | -0.41x | $-8.17 Million | $-8.55 Million | $19.88 Million | — |